Success in precision medicine depends on accessing high-quality genetic and molecular data that, in conjunction with comprehensive clinical data, can lead to more effective therapies. Although omics data is available on public databases, doctors are not yet able to extract useful value from it owing to its sheer volume and heterogeneity.

While there are solutions to this problem - based on Big Data and Artificial Intelligence - these are mainly designed for specific diseases; this while there are 400 million patients around the globe affected by rare diseases. Kazaam Lab’s solution is an innovative, electronic, passive dosimeter based on a CMOS Floating Gate sensor monolithically implemented on a single chip.

Simona Rombo, an associate professor of computer science at the University of Palermo and one of the founders and the CEO of Kazaam Lab, spoke with Andrew Wrobel about the challenges her start-up has faced and overcome, as well as offering some tips for young researchers developing health solutions.